UW16032 – Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

The PI of this project was: Mark Albertini, MD

This project was funded by:

The term of this project was: January 2018 to January 1970

The number of subjects scanned during this project was: